Effect of niacin on erectile function in men suffering erectile dysfunction and dyslipidemia.

  title={Effect of niacin on erectile function in men suffering erectile dysfunction and dyslipidemia.},
  author={Chi-Fai Ng and Chui-ping Lee and Allen Ho and Vivian Wing Yan Lee},
  journal={The journal of sexual medicine},
  volume={8 10},
INTRODUCTION Dyslipidemia is closely related to erectile dysfunction (ED. [] Key MethodMETHODS A single center prospective randomized placebo-controlled parallel-group trial was conducted. One hundred sixty male patients with ED and dyslipidemia were randomized in a one-to-one ratio to receive up to 1,500 mg oral niacin daily or placebo for 12 weeks.

Figures and Tables from this paper

The Association Between Dyslipidemia and Its Treatment with Erectile Dysfunction
This review aims to analyze the relationship between dyslipidemia and erectile dysfunction, the extent of this correlation, and the pathophysiological mechanisms mediating this relationship, incorporating current evidence.
l-arginine and Erectile Dysfunction
Positive evidence is available for the efficacy of l-arginine and its various combinations and further research with larger sample sizes and standardized tools are required to recommend the routine use of these products in erectile dysfunction.
Nutritional supplements and erectile dysfunction
Complementary and Alternative Medicine for Erectile Dysfunction, Testosterone Replacement Therapy, and Female Sexual Dysfunction
Contrary to popular belief, there are some CAM options for patients concerned about ED and FSD, but there are very limited to no options currently in the area of TRT.
Effects of Phenotypic and Genotypic Factors on the Lipid Responses to Niacin in Chinese Patients With Dyslipidemia
Baseline lipid levels were the main determinants of lipid responses especially for LDL-C, and the DGAT2 rs3060 polymorphism might influence the lipid responses depending on baseline phenotype, but this association did not persist after adjustment for the baseline lipid levels.
Alternative medicine and herbal remedies in the treatment of erectile dysfunction: A systematic review
ABSTRACT Objectives: To systematically review and discuss the current evidence from placebo-controlled clinical trials that investigated the use of alternative medicines and herbal remedies in the
There was a significant difference in serum vitamin B 3 levels between the smokers and non-smokers and this study concluded that smoking is a bad habit observed in every society all over the world with multiple consequences.
Nicotinic acid as a lipid-modifying drug--a review.
Editorial Comment to Extracorporeal shockwave therapy in the treatment of erectile dysfunction: A prospective, randomized, double‐blinded, placebo controlled study
  • A. GoelSaurabh Gupta
  • Medicine, Psychology
    International journal of urology : official journal of the Japanese Urological Association
  • 2014
By fully evaluating the efficacy of this new therapy, it would be able to determine if Li-ESWT could become a recognized curative treatment in patients with ED.


Efficacy of phosphodiesterase type 5 inhibitor treatment in men with erectile dysfunction and dyslipidemia: a post hoc analysis of the vardenafil statin study.
Vardenafil was effective in men with dyslipidemia regardless of LDL-C levels, TC/HDL-C ratio, and/or presence of metabolic syndrome.
Effect of correcting serum cholesterol levels on erectile function in patients with vasculogenic erectile dysfunction
Objective. This study evaluated the effect of correction of serum cholesterol levels on erectile function and sildenafil treatment in patients with erectile dysfunction who have only
Erectile dysfunction and dyslipidemia: relevance and role of phosphodiesterase type-5 inhibitors and statins.
While dyslipidemia and ED are important concerns for clinicians, there exists a gap that needs to be closed between the number of individuals who have either or both conditions and those who are receiving appropriate therapy based on evidence and patient-driven goals regarding clinical outcomes.
Atorvastatin improves the response to sildenafil in hypercholesterolemic men with erectile dysfunction not initially responsive to sildenafil
Subgroup analyses did reveal trends in the atorvastatin group to indicate that a change in the IIEF-5 score is affected by age, severity of ED and baseline serum levels of LDL, but further investigation is needed to test the usefulness of long-term atorVastatin administration to restore erectile function in sildenafil nonresponders.
Can atorvastatin improve the response to sildenafil in men with erectile dysfunction not initially responsive to sildenafil? Hypothesis and pilot trial results.
Treatment with atorvastatin improved sexual function and the response to oral sildenafil in men who did not initially respond to treatment with sildinafil and deserves further testing in a large clinical trial.
Vasculogenic erectile dysfunction and metabolic syndrome.
The prevalence of ED increases with advanced age and with the presence of a systemic disease, and the use ofpenile Doppler ultrasonography should be considered for the evaluation of penile vascular structures in ED patients.
The effects of quinapril and atorvastatin on the responsiveness to sildenafil in men with erectile dysfunction
Treatment with quinapril, in combination with sildenafil, improved ED in men with suboptimal response to sildinafil alone, and atorvastatin demonstrated a trend toward improved ED.
Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation.
Atorvastatin improves diabetes-related ED and restores sildenafil responsiveness, most probably by inhibiting RhoA/ROCK signaling, which underlies several high-glucose-induced derangements in penile smooth muscle cell commitment.
The International Index of Erectile Function (IIEF): a state-of-the-science review
This review summarizes early stages in the psychometric validation of the IIEF, its subsequent adoption in randomized clinical trials with sildenafil and other ED therapies, and its use in classifying ED severity and prevalence.